Potential Benefit of Mineralocorticoid Receptor Antagonists in Kidney Diseases | IntechOpen
Role of Mineralocorticoid Receptor Antagonists in Cardiovascular Disease | Circulation Research
Aldosterone antagonists
Angiotensin-II Receptor Antagonists: Their Place in Therapy - American Family Physician
Aldosterone sensitivity: an opportunity to explore the pathogenesis of hypertension | American Journal of Physiology-Renal Physiology
Aldosterone
Antimineralocorticoid - Wikipedia
ALDOSTERONE RECEPTOR ANTAGONISTS
Pharmacology of Heart Failure Treatments: Part 1 - ppt download
Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease - Kidney International Reports
Potassium Sparing Diuretics - Pharmacological Actions, Pharmacokinetics, Uses, Adverse Effects, Interactions | Pharmacology
Biomolecules | Free Full-Text | Spironolactone and XPB: An Old Drug with a New Molecular Target | HTML
Aldosterone Antagonism in Chronic Kidney Disease | American Society of Nephrology
![PDF] The role of aldosterone receptor antagonists in the management of heart failure: An update | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/18579cba6f8135b6c5e499b814797ac583649574/2-Figure1-1.png "PDF] The role of aldosterone receptor antagonists in the management of heart failure: An update | Semantic Scholar")
PDF] The role of aldosterone receptor antagonists in the management of heart failure: An update | Semantic Scholar
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies - The Lancet Diabetes & Endocrinology
Frontiers | Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease | Pharmacology
Diuretics II
The Pharmacodynamics of Diuretics
Evidence for the use of mineralocorticoid receptor antagonists in the treatment of coronary artery disease and post-angioplasty restenosis - ScienceDirect
Mineralocorticoids and mineralocorticoid antagonists | Osmosis
Management of cirrhotic ascites: Physiological basis of diuretic action - European Journal of Internal Medicine
Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology - Kidney International
Potassium-sparing Diuretics | Concise Medical Knowledge
Emerging cardiovascular indications of mineralocorticoid receptor antagonists: Trends in Endocrinology & Metabolism
Clinical use of aldosterone antagonists for slowing progression of chronic kidney disease: From the physiological basis to clinical application | Boletín Médico del Hospital Infantil de México (English Edition)
Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology
![potassium_sparing_diuretics [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/ksparing.png "potassium_sparing_diuretics [TUSOM | Pharmwiki]")